Floatz logo

299 assets in Alzheimer Disease

Therapeutic assets addressing Alzheimer Disease, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
mk-1708
Alzheimer Disease
Merck Sharp & Dohme LLCP1CC (42)
mk-1942
Alzheimer Disease
Merck Sharp & Dohme LLCP2CC (42)
Nmra-323511
Alzheimer Disease
Neumora Therapeutics, Inc.P1CC (42)
snp318
Alzheimer Disease
SciNeuroP1CC (42)
[18F]MC225
Alzheimer Disease
University Medical Center GroningenP1/2CC (41)
64Cu-FBP8
Alzheimer Disease
Massachusetts General HospitalP1/2CC (41)
Alzn002
Alzheimer Disease
Alzamend Neuro, Inc.P1/2CC (41)
Aro-Mapt-Sc
Alzheimer Disease
Arrowhead PharmaceuticalsP1/2CC (41)
Brivaracetam
Alzheimer Disease
University of California, Los AngelesP1/2CC (41)
Cellready®
Alzheimer Disease
University Hospital, ToulouseP1/2CC (41)
E22W mutant amyloid-beta peptide
Alzheimer Disease
Alzamend Neuro, Inc.P1/2CC (41)
ivl3003
Alzheimer Disease
Inventage Lab., Inc.P1/2CC (41)
Latozinemab
Alzheimer Disease
Alzamend Neuro, Inc.P1/2CC (41)
Niacin
Alzheimer Disease
Indiana UniversityP1/2CC (41)
nsc001
Alzheimer Disease
NSC-TherapeuticsP1/2CC (41)
Salicylamine Acetate
Alzheimer Disease
MTI Biotech IncP1/2CC (41)
AIR
Alzheimer Disease
University of California, San DiegoP1CC (40)
Alia-1758
Alzheimer Disease
AbbVieP1CC (40)
Alz-101
Alzheimer Disease
Alzinova ABP1CC (40)
av-1959r
Alzheimer Disease
Nuravax, Inc.P1CC (40)
cms121
Alzheimer Disease
Virogenics, Inc.P1CC (40)
GB-5001
Alzheimer Disease
G2GBio, Inc.P1CC (40)
Lispro-Ph20 Component Rhuph20
Alzheimer Disease
Acumen PharmaceuticalsP1CC (40)
NH280105
Alzheimer Disease
Jiangsu Nhwa Pharmaceutical Co., Ltd.P1CC (40)
Oxygen
Alzheimer Disease
University of California, San DiegoP1CC (40)
vg-3927
Alzheimer Disease
Vigil Neuroscience, Inc.P1CC (40)
11C-MC1
Alzheimer Disease
National Institute of Mental Health (NIMH)P1C (39)
[18F]ACI-19626
Alzheimer Disease
AC Immune SAEarly P1C (39)
aav2-bdnf gene therapy
Alzheimer Disease
Mark TuszynskiP1C (39)
Aln-5288
Alzheimer Disease
Alnylam PharmaceuticalsP1C (39)
Centella Asiatica Water Extract Product
Alzheimer Disease
Oregon Health and Science UniversityP1C (39)
CS6253
Alzheimer Disease
Artery Therapeutics, Inc.Early P1C (39)
PS13
Alzheimer Disease
National Institute of Mental Health (NIMH)P1C (39)
Recombinant Human Serum Albumin
Alzheimer Disease
Protgen LtdEarly P1C (39)
ro7812653
Alzheimer Disease
Hoffmann-La RocheP1C (39)
[ 18f]3f4ap
Alzheimer Disease
Yale UniversityP1C (37)
18F-NAV-4694
Alzheimer Disease
Tharick PascoalP1C (37)
ac-1202
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-010
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-02
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-03
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-04
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-05
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-06
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-07
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-09
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-P
Alzheimer Disease
CerecinP1C (37)
Adel-Y01 - Mci/Ad
Alzheimer Disease
Alzheimer's Disease Expert Lab (ADEL), Inc.P1C (37)
Apnmab005
Alzheimer Disease
APRINOIA Therapeutics, LLCP1C (37)
av-1959d
Alzheimer Disease
Institute for Molecular MedicineP1C (37)
Showing 201 to 250 of 299 assets
PreviousPage 5 of 6Next